Mario van der Stelt

Country flagNetherlands

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (13)

Covalent fluorescent probes have emerged as versatile chemical tools to visualise active enzymes in complex biological systems. When tailored for specific applications, ranging from activity‐based protein profiling for drug development to high spatiotemporal resolution imaging of enzymatic activities, these probes provide unique insights into rapid lipid metabolism. The recent development of reverse‐designing optimised inhibitors into probes, together with improved analytical techniques, is rapidly advancing our ability to resolve enzyme function in great detail. In this mini‐review, we summarise the current landscape of covalent fluorescent probes for the 2‐arachidonoylglycerol (2‐AG) metabolising enzymes (diacylglycerol lipase, monoacylglycerol lipase, ABHD6 and ABHD12), highlighting the discoveries they have enabled and discussing strategies to address gaps where probes remain lacking.

Year:

2026

Peripherally restricted cannabinoid CB1 receptor antagonists without central side effects hold promise for treating metabolic disorders including diabetes and obesity. In atherosclerosis, the specific effects of peripheral endothelial CB1 signaling remain incompletely understood. Here, we report the expression of the CB1 encoding gene CNR1 in arterial endothelial cells of human plaques. We also show that endothelial CNR1 expression is increased by oscillatory shear stress (OSS) in human aortic endothelial cells (HAoECs) and is higher in atheroprone regions than in atheroresistant regions of murine aortas. Endothelial CB1 deficiency (Cnr1EC-KO) in atheroprone mice resulted in pronounced endothelial phenotypic changes with reduced vascular inflammation and permeability. This led to reduced plaque development with a lower lipid content in female mice, whereas attenuated plaque development, but no changes in plaque lipid content were found in males. Reduced white and brown adipose tissue mass and liver steatosis upon Cnr1EC-KO were observed in both males and females. Ex vivo imaging of female carotid arteries revealed less low density lipoprotein (Dil-LDL) uptake in Cnr1EC-KO. This was accompanied by reduced endothelial caveolin-1 (CAV1) expression, a key structural protein involved in lipid transcytosis, which was only observed in female Cnr1EC-KO mice. In vitro, pharmacological blocking with CB1 antagonist AM281 reproduced the inhibition of CAV1 expression and Dil-LDL uptake in response to atheroprone OSS in HAoECs, which was dependent on cAMP-mediated PKA activation. Conversely, the CB1 agonist ACEA increased Dil-LDL uptake and CAV1 expression in HAoECs. Chronic treatment of atherosclerotic mice with the peripheral CB1 antagonist JD-5037 reduced plaque progression and endothelial CAV1 expression in female mice. Consistent with more pronounced effects in females, HAECs treated with the estrogen receptor ligand estradiol exhibited increased CNR1 and CAV1 expression. These results support a proatherogenic role of endothelial CB1, which appears to be more pronounced in females.

Year:

2025

The activation of T-cells is heavily shaped by the nutrients that are available during activation. Fatty acids can have highly pleiotropic effects in this process. On the one hand, they are essential for driving T-cell activation, yet on the other hand they can affect curtailed T-cell activation. These differences are likely dependent on the nature and absolute uptake of the fatty acids. Quantifying the uptake of specific FAs by individual cells and studying the effect on the phenotype of the cell is currently not possible with existing tools. Here we therefore use the live-cell compatible Inverse Electron-Demand Diels-Alder reaction combined with the synthesis of saturated, unsaturated and polyunsaturated fatty acids carrying the 1-carbon cyclopropene click group. Single cell uptake studies of these various clickable FAs in primary immune cell mixtures show highly divergent uptake behaviour between different immune cells, with polyunsaturated fatty acids markedly preferred by all immune cells tested.

Year:

2025

Visualizing signaling systems in the brain with high spatial resolution is critical to understand brain function and to develop therapeutics. Especially enzymes are often regulated on the post-translational level, resulting in a disconnect between protein levels and activity. Conventional antibody-based methods have limitations, including potential cross reactivity and the inability of antibodies to discriminate between active and inactive enzyme states. Monoacylglycerol lipase (MAGL), an enzyme degrading the neuroprotective endocannabinoid 2-arachidonoylglycerol, is the target of inhibitors currently in clinical trials for the treatment of several neurological disorders. To support translational and (pre)clinical studies and fully realize the therapeutic opportunities of MAGL inhibitors, it is essential to map the spatial distribution of MAGL activity throughout the brain in both health and disease. Here, we introduce selective fluorescent activity-based probes for MAGL enabling direct visualization of its enzymatic activity in lysates, cultured cells and tissue sections. We show that oxidative stress, which inactivates MAGL through the oxidation of regulatory cysteines, reduces probe labeling, thereby validating the probes activity-dependence. Extending this approach, we developed an activity-based histology protocol to visualize MAGL activity in fresh-frozen mouse and human brain tissues. This approach revealed robust MAGL activity in astrocytes and presynaptic terminals within the mouse hippocampus, and further allows detection of MAGL activity in the human cerebral cortex. Collectively, these findings establish selective activity-based probes as powerful tools mapping MAGL activity with high spatial resolution across mammalian brain tissue.

Year:

2025

Introduction While it has become clear that alterations in lipid metabolism are associated with AD, it is unclear how they contribute to both cognitive decline and the pathophysiology of AD. Methods We performed lipidomics and activity-based protein profiling in the frontal cortex of control, AD and resilient donors, i.e. individuals with AD pathology without cognitive decline. Subsequently we integrated these data using multi-omics factor analysis and correlated the multi-omics profiles to disease and clinical parameters. Results The most pronounced alterations in lipids were in the ω6-derived oxylipins, which were particularly increased in the AD patients. Both triacylglycerols (TAGs) and lipid droplets were more abundant in the AD donors compared to the resilient donors. Enzyme activities showed a similar direction in the AD and resilient donors, including decreased activity of ABHD6. Multi-omics factor analysis showed that increased oxylipins, loss of inhibitory cells, synaptic genes and genes related to the inflammatory response were associated with Aβ plaque load in both AD and resilient donors. Conclusion Our multi-omics data show a response associated with Aβ load shared among AD and resilient donors and, for the first time, reduced lipid droplets in resilient donors.

Year:

2025

Acetaminophen (APAP) is commonly used as a pain and fever reliever, but its mechanisms remain unclear. Conflicting evidence implicates the endocannabinoid system in the effects of APAP. We tested the hypothesis that the analgesic effects of APAP were dependent upon both CB1 cannabinoid receptors and diacylglycerol lipase (DAGL), an enzyme which catalyzes formation of the endocannabinoid 2-arachidonoylglycerol. We examined the impact of APAP, administered in the presence and absence of DAGL inhibitors, on mechanical hypersensitivity in mice using models of inflammatory (induced by intraplantar injection of complete Freunds adjuvant (CFA)) and post-surgical (induced by incisional injury) pain. Pharmacological specificity was assessed using global (Rimonabant, AM251) and peripherally restricted (AM6545) CB1 antagonists. APAP produced a dose-dependent attenuation of inflammation-induced mechanical hypersensitivity, but did not alter peripheral edema in the CFA-injected paw. APAP also attenuated mechanical hypersensitivity in mice with incisional injury. The DAGL inhibitors, RHC-80267 or DO34, attenuated the anti-allodynic effects of APAP in both models of pain. CB1 receptor antagonists (Rimonabant and/or AM251) suppressed the antinociceptive effect of APAP in both pain models. The peripherally-restricted CB1 antagonist AM6545 did not alter the anti-allodynic effects of APAP. We also assessed the impact of APAP on tail-flick antinociception, locomotor behavior, and body temperature. APAP produced hypothermia and hypolocomotion at the highest dose, but these effects were not blocked by RHC-80267 or AM251. APAP did not produce tail flick antinociception. Our studies demonstrate that the analgesic effects of APAP observed in mouse models of pathological pain require both DAGL and CB1 activation. Our findings support a potential mechanism of APAP-induced analgesic action involving the enzyme DAGL and CB1 receptors.

Year:

2025

While it is known that endocannabinoids (eCB) modulate multiple neuronal functions, the molecular mechanism governing their release and transport remains elusive. Here, we propose an “ on-demand release ” model, wherein the formation of microvesicles, a specific group of extracellular vesicles (EVs) containing the eCB, 2-arachidonoylglycerol (2-AG), is an important step. A coculture model system that combines a reporter cell line expressing the fluorescent eCB sensor, G protein-coupled receptor-based (GRAB) eCB2.0 , and neuronal cells revealed that neurons release EVs containing 2-AG, but not anandamide, in a stimulus-dependent process regulated by protein kinase C, Diacylglycerol lipase, Adenosinediphosphate (ADP) ribosylation factor 6 (Arf6), and which was sensitive to inhibitors of eCB facilitated diffusion. A vesicle contained approximately 2,000 2-AG molecules. Accordingly, hippocampal eCB-mediated synaptic plasticity was modulated by Arf6 and transport inhibitors. The “ on-demand release ” model, supported by mathematical analysis, offers a cohesive framework for understanding eCB trafficking at the molecular level and suggests that microvesicles carrying signaling lipids in their membrane regulate neuronal functions in parallel to canonical synaptic vesicles.

Year:

2025

The cannabinoid receptor type 2 (CB 2 R) is a G protein‐coupled receptor with therapeutic potential for the treatment of inflammatory disorders. Fluorescent probes are desirable to study its receptor localization, expression and occupancy. Previously, we have reported a photoaffinity probe LEI‐121 that stabilized the inactive conformation of the CB 2 R. Here, we report the structure‐based design of a novel bifunctional probe that captures the active conformation of the CB 2 R upon irradiation with light. An alkyne handle was incorporated to visualize the receptor using click‐chemistry with fluorophore‐azides. These probes may hold promise to study different receptor conformations in relation to their cellular localization and function.

Year:

2024

Multiple sclerosis (MS) is a neuroinflammatory disease characterized by expanding demyelinating lesions, leading to severe and irreversible disability. The mechanisms driving lesion expansion, however, remain poorly understood. Here, using a multi-omics approach, we identified foamy microglia as primary contributors to the molecular profile of lesions and disease progression in secondary progressive MS. Lesions with foamy microglia are marked by the accumulation of cholesterol esters, bismonoacylglycerolphosphates (BMP), and oxylipins, along with high B-cell infiltration, increased levels of immunoglobulin G1, and elevated expression of Fcγ- and complement receptors. Lesions with foamy GPNMB + -microglia display markers of enhanced phagocytosis, lipid metabolism, lysosomal dysfunction, and antigen presentation, but lack classical pro-inflammatory markers. Our data suggest that sustained phagocytosis of myelin overwhelms microglial endo-lysosomal capacity, leading to lipid droplet and oxylipin formation. This microglial phenotype may induce further recruitment of adaptive immune cells, axonal damage, drive lesion expansion and prevent remyelination. Monoacylglycerol lipase, involved in producing oxylipin precursors, was identified as a potential therapeutic target to disrupt this cycle and prevent chronic lesion expansion.

Year:

2024

The human genome encodes 518 protein kinases that are pivotal for drug discovery in various therapeutic areas such as cancer and autoimmune disorders. The majority of kinase inhibitors target the conserved ATP-binding pocket, making it difficult to develop selective inhibitors. To characterize and prioritize kinase-inhibiting drug candidates, efficient methods are desired to determine target engagement across the cellular kinome. In this study, we present CellEKT (Cellular Endogenous Kinase Targeting), an optimized and robust chemical proteomics platform for investigating cellular target engagement of endogenously expressed kinases using the sulfonyl fluoride-based probe XO44 and two new probes ALX005 and ALX011 . The optimized workflow enabled the determination of the kinome interaction landscape of covalent and non-covalent drugs across over 300 kinases, expressed as half maximum inhibitory concentration (IC50), which were validated using distinct platforms like phosphoproteomics and NanoBRET. With CellEKT, target engagement profiles were linked to their substrate space. CellEKT has the ability to decrypt drug actions and to guide the discovery and development of drugs. Graphical abstract

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (21)

Sabine Steffens

Professor

Ludwig-Maximilians-Universität München

GERMANY
View details

Jitao David Zhang

Privatdozent

University of Basel

SWITZERLAND
View details

Andrea G. Hohmann

Linda and Jack Gill Chair and Professor

Indiana University Bloomington

UNITED STATES
View details

Dirk-Jan Scheffers

Professor of Bacterial Cell Biology

University of Groningen

NETHERLANDS
View details

Thomas Hankemeier

Professor at Leiden University

Leiden University

NETHERLANDS
View details

Marco van Eijk

Assistant Professor

-

NETHERLANDS
View details

Lars Maegdefessel

Assistant Professor

Karolinska Institutet

SWEDEN
View details

Nadja Sachs

Technical University of Munich

GERMANY
View details

Alexandros Makriyannis

Director

Northeastern University

UNITED STATES
View details

Ingeborg Huitinga

professor

Netherlands Institute for Neuroscience

NETHERLANDS
View details

Elise Dusseldorp

Full Professor

Leiden University

NETHERLANDS
View details

Connie R Jimenez

Professor of Translational OncoProteomics, Head of OncoProteomics Laboratory

-

NETHERLANDS
View details

J.G.C. van Hasselt

Full professor

Leiden University

NETHERLANDS
View details

Albert Heck

Utrecht University

NETHERLANDS
View details

Amy Harms

Leiden University

NETHERLANDS
View details

Joost Willemse

Facility manager / Assistant professor

Leiden University

NETHERLANDS
View details

Wiep Klaas Smits

Associate Professor

Leiden University Medical Center

NETHERLANDS
View details

Raquel Guillamat-Prats

Emergent group leader

Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

SPAIN
View details

Jan Paul Medema

Head of department

AmsterdamUMC

NETHERLANDS
View details

Nathaniel I. Martin

Leiden University

NETHERLANDS
View details

Alexander Faussner

PI/Prof

Klinikum der Universität München

GERMANY
View details